Duboscq, C., Martinuzzo, M. E., Ceresetto, J., Lopez, M., Barrera, L., Oyhamburu, J., & Stemmelin, G. (2018). The fibrinogen prothrombin time‐derived method is not useful in patients anticoagulated with low molecular weight heparins or rivaroxaban. Journal of thrombosis and haemostasis, 16(8), 1626-1631. https://doi.org/10.1111/jth.14158
Citace podle Chicago (17th ed.)Duboscq, C., M. E. Martinuzzo, J. Ceresetto, M. Lopez, L. Barrera, J. Oyhamburu, a G. Stemmelin. "The Fibrinogen Prothrombin Time‐derived Method Is Not Useful in Patients Anticoagulated with Low Molecular Weight Heparins or Rivaroxaban." Journal of Thrombosis and Haemostasis 16, no. 8 (2018): 1626-1631. https://doi.org/10.1111/jth.14158.
Citace podle MLA (9th ed.)Duboscq, C., et al. "The Fibrinogen Prothrombin Time‐derived Method Is Not Useful in Patients Anticoagulated with Low Molecular Weight Heparins or Rivaroxaban." Journal of Thrombosis and Haemostasis, vol. 16, no. 8, 2018, pp. 1626-1631, https://doi.org/10.1111/jth.14158.